State Street’s Bionano Genomics BNGO Stock Holding History
Bought
Maintained
Sold
Other funds holding BNGO
SS
CCM
State Street's BNGO Position: Q1 2025 in Review
State Street sold out of Bionano Genomics (BNGO) in Q1 2025, closing a stake of 1,851 shares — an estimated $32K sold.
State Street first reported a position in BNGO in Q1 2021 and held it in 16 quarters. The position peaked at $55.1M in Q2 2021. 30 funds tracked by Wall St. Rank hold BNGO as of Q1 2025.
- State Street reported no remaining Bionano Genomics position as of Q1 2025 after selling out during the quarter.
- State Street sold 1,851 Bionano Genomics shares in Q1 2025, an estimated $32K.
- State Street first reported a position in Bionano Genomics in Q1 2021 and held it in 16 quarters.
- State Street's Bionano Genomics position peaked at $55.1M in Q2 2021.
- 30 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2025.
Based on State Street's 13F filing for Q1 2025, filed 15 May 2025.